Γ—

Repair Biotechnologies

Organization Description

Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), a first in class approach to therapy aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?

Team

Mourad Topors, Ph.D.

Repair Biotechnologies - Chief Scientific Officer

Reason

Repair Biotechnologies - CEO

Bill Cherman

Repair Biotechnologies